Thermosensitive Chitosan-β-Glycerophosphate Hydrogels as Targeted Drug Delivery Systems: An Overview on Preparation and Their Applications

Table 2

Factors influencing gelation, chitosan-β-glycerophosphate.

MW	Con	DDA %	Time (min)	pH	GP	T (°C)	Drug	Reference
310–375	0.8 g	103	5	7	2 g	37	Aspirin	[64]
62	0.1%	82	1.6	7.4	12%	30	Mitomycin-c	[65]
124	0.1%	72	1.4	7.4	12%	29.8	Mitomycin-c	[65]
370	0.1%	71	1	7.4	12%	29.6	Mitomycin-c	[65]
650	20 mg/mL	85	10	7.35	3%	37	Curcumin	[66]
200	1.8%	91	12	6.88	9	37	Docetaxel	[67]
200	1.8%	91	5	6.97	12	37	Docetaxel	[67]
200	1.4%	91	>120	6.75	6	37	Docetaxel	[67]
200	1.4%	91	61	6.83	9%	37	Docetaxel	[67]
306.12	2%%	95	2	7.63	14%	37	Insulin	[68]
306.12	2%%	95	3	7.52	12%	37	Insulin	[68]
306.12	2%%	95	5	7.45	10%	37	Insulin	[68]
306.12	2%%	95	14	6.91	5%	37	Insulin	[68]